Abstract
The concept of disability-adjusted life years (DALYs) has rapidly gained in popularity in health policy, and considerable research resources are being allocated to this field. Proponents of DALYs suggest that the measure can be used both as a "gross domestic product of health" and to help in setting priorities in health policy. This study investigates the usefulness of DALYs and contends that DALYs, as the measure is currently understood, cannot be used for either of these two purposes. The DALYs procedure does not produce a useful measure of population health, and its use in priority setting is ethically questionable.
Similar content being viewed by others
References
Anand S, Hanson K (1997) Disability-adjusted life years: a critical review. J Health Econ 16:685–702
Anand S, Hanson K (1998) DALYs: efficiency versus equity. World Dev 26:307–310
Andersson F, Lyttkens CH (1999) Preferences for equity in health behind a veil of ignorance. Health Econ 8:369–378
Anonymous (1998) European disability weights project. BIOMED project PL 963253. Newsletter 98–01
Arnesen T, Nord E (1999) The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ 319:1423–1425
Bleichrodt H (1997) Health utility indices and equity considerations. J Health Econ 16:65–91
Bobadilla JL, Cowley P (1995) Designing and implementing packages of essential health services. J Int Dev 7:543–554
Boyd NF, et al (1990) Whose utilities for decision analysis? Med Decis Making 10:58–67
Cairns J (1992) Health, wealth and time preference. Project Appraisal 7:31–40
Cairns J (1994) Valuing future benefits. Health Econ 3:221–229
Cropper ML, Aydede SK, Portney PR (1992) Rates of time preference for saving lives. Am Econ Rev 82:469–472
Cropper ML, Aydede SK, Portney PR (1994) Preferences for life saving programmes: how the public discounts time and age. J Risk Uncertainty 8:243–265
Dolan P (1998) The measurement of individual utility and social welfare. J Health Econ 17:39–52
Drèze J, Stern N (1987) The theory of cost-benefit analysis. In: Auerbach AJ, Feldstein M (eds) Handbook of public economics, vol II. Amsterdam: North-Holland, pp 909–989
Drummond MF, et al (1997) Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press
Essink-Bot M-L, et al (2002) Cross-national comparability of burden of disease estimates: the European Disability Weights Project. Bull World Health Organ 80:644–652
Foster J, Sen A (1997) On economic inequality after a quarter of a century. In: Sen A (eds) On economic inequality. Oxford: Clarendon
Gold MR, et al (eds) (1996) Cost-effectiveness in health and medicine. New York: Oxford University Press
Gravelle H, Smith D (2001) Discounting for health effects in cost-benefit and cost-effectiveness analysis. Health Econ 10:587–599
Gyrd-Hansen D, Søgaard J (1998) Discounting life-years: wither time preferences? Health Econ 7:121–127
Höjgård S, et al (2002) Discounting and clinical decision making. Health Econ 11:355–370
Johannesson M, Gerdtham U-G (1996) A note on the estimation of the equity-efficiency trade-off for QALYs. J Health Econ 15:359–368
Johannesson M, Jönsson B, Karlsson G (1996) Outcome measurement in economic evaluation. Health Econ 5:279–296
Kenkel D (1997) On valuing morbidity, cost-effectiveness analysis, and being rude. J Health Econ 16:749–757
Lindholm L, Rosén M (1998) On the measurement of the nation's equity adjusted health. Health Econ 7:621–228
Lyttkens CH (1994) Prioritering i etik och praktik—en hälsoekonomisk analys av prioriteringsutredningen. Ekonomisk Debatt 22:595–606
Lyttkens CH (1994) QALY league tables. Health Econ 3:57–58
Lyttkens CH (1998) Economic analysis of socio-economic differences in health. In: Arve-Parès B (ed) Inequality in health—a Swedish perspective. Stockholm: Swedish Council for Social Research, pp 285–317
Meltzer D (1997) Accounting for future costs in medical cost-effectiveness analysis. J Health Econ 16:33–64
Mooney G, Wiseman V (2000) Burden of disease and priority setting. Health Econ 9:369–372
Mooney G, Irwig L, Leeder S (1997) Priority setting in health care: unburdening from the burden of disease. Aus N Z J Public Health 21:680–681
Murray CJL (1996) Rethinking DALYs. In: Murray CJL, Lopez AD (eds) The global burden of disease. Cambridge: Harvard University Press, pp 1–98
Murray CJL, Acharya AK (1997) Understanding DALYs. J Health Econ 16:703–730
Murray CJL, Lopez AD (eds) (1996) The global burden of disease. Cambridge: Harvard University Press
Murray CJL, Lopez AD (2000) Progress and directions in refining the global burden of disease approach: a response to Williams. Health Econ 9:69–82
Murray CJL, Salomon JA, Mathers C (1999) A critical examination of summary measures of population health. GPE discussion paper no 2. Geneva: World Health Organization
Nord E (1995) The person-trade-off approach to valuing health care programs. Med Decis Making 15:201–208
Nord E (1999) Cost-value analysis in health care. New York: Cambridge University Press
Nord E (1999) My goodness—and yours. A history, and some possible futures, of DALY meanings and valuation procedures. Paper for WHO's Global Conference on Summary Measures of Population health, Marrakech, December
Nord E, et al (1995) Maximizing health benefits vs egalitarianism: an Australian survey of health issues. Soc Sci Med 41:1429–1437
Nord E, et al (1999) Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Econ 8:25–39
Olsen JA (1993) On what basis should health be discounted. J Health Econ 12:39–53
Olsen JA (1993) Time preferences for health gains: an empirical investigation. Health Econ 2:257–265
Olsen JA (1994) Persons vs years: two ways of eliciting implicit weights. Health Econ 3:39–46
Olsen JA (1997) Theories of justice and their implications for priority setting in health care. J Health Econ 16:625–639
Peterson S, Backlund I, Diderichsen F (1998) Sjukdomsbördan i Sverige—en svensk DALY-kalkyl [The burden of disease in Sweden—a Swedish DALY-calculation]. Stockholm: Folkhälsoinstitutet
Pol MM van der, Cairns J (2000) Negative and zero time preferences for health. Health Econ 9:171–175
Redelmeier DA, Heller DM (1993) Time preference in medical decision making and cost-effectiveness analysis. Med Decis Making 13:212–303
Sacket DL, Torrance GW (1978) The utility of different health states as perceived by the general public. J Chronic Dis 31:697–704
Ubel PA, Richardson J, Menzel P (2000) Societal value, the person trade-off and the dilemma of whose values to measure for cost-effectiveness analysis. Health Econ 9:127–136
Vårdens svåra val [The difficult choice in health care]. SOU 1995:5. Stockholm: Slutbetänkande av Prioriteringsutredningen.
Wagstaff A (1991) QALYs and the equity-efficiency trade-off. J Health Econ 10:21–41
Williams A (1988) Ethics and efficiency in the provision of health care. In: Bell JM, Mendus S (eds) Philosophy and medical care, supplement to Philosophy
Williams A (1997) Intergenerational equity: an exploration of the 'fair innings' argument. Health Econ 6:117–132
Williams A (1999) Calculating the global burden of disease: time for a strategic reappraisal? Health Econ 8:1–8
Williams A (2000) Comments on the response by Murray and Lopez. Health Econ 9:83–86
World Bank (1993) World development report 1993. Investing in health. New York: Oxford University Press
World Health Organization (2002) World health report 2002. Reducing risks, promoting healthy life. Statistical Annex, p 172. www.who.int/whr/2002/en/, accessed 28 January 2003
Acknowledgements
This research received financial support from the Swedish Medical Research Council (grant no. K99/K2000-27P-10737-06C/07A). The research mainly took place at the Department of Community Medicine, Lund University, and Lund University Centre for Health Economics. Helpful comments from three anonymous referees, Kristina Burström, Kjeld Møller Pedersen, Erik Nord, Sören Höjgård, Björn Lindgren, Peter Martinsson, and Katarina Steen Carlsson, as well as participants at several meetings, are gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lyttkens, C.H. Time to disable DALYs?. HEPAC 4, 195–202 (2003). https://doi.org/10.1007/s10198-003-0169-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10198-003-0169-2